Trial
NCT01678924
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Allergan
Collaborators
—
Condition
Neuralgia, Postherpetic
Intervention
AGN-214868
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-07